Literature DB >> 19296170

Time-dependent morphologic change in depressed-type early gastric cancer.

Jong Pil Im1, Sang Gyun Kim, Joo Sung Kim, Hyun Chae Jung, In Sung Song.   

Abstract

BACKGROUND: Depressed-type early gastric cancer (EGC) is known to repeat improvement and exacerbation of ulceration during its natural course, forming a "malignant cycle." However, it is difficult to observe the malignant cycle of EGC in clinical practice, and little is known about the clinicopathologic factors associated with this cycle. This study aimed to evaluate the malignant cycle of EGC and to determine the clinicopathologic factors associated with the time-dependent morphologic change of EGC.
METHODS: The medical records of EGC patients treated at the Seoul National University Hospital were retrospectively reviewed with two or more comparable endoscopic photos taken between March 1999 and December 2005. The ulcer stages in EGC were classified by the gastric ulcer stage system and evaluated for time-dependent morphologic changes according to the relevant factors.
RESULTS: In this study, 231 cases of depressed-type EGC were evaluated. At the follow-up endoscopy after a median interval of 23 days, a change in ulcer stage was observed in 66 patients (29%), with improvement in 45 patients (20%) and exacerbation in 21 patients (9%). Of the 177 patients who demonstrated an active or healing stage, 45 (25%) showed improvement and 10 (6%) exhibited exacerbation. The multivariate analysis showed that the usage of antisecretory medications, mucosal cancer, and a longer interval between the two endoscopic examinations were the factors that had a significant association with improvement of the ulcer stage.
CONCLUSIONS: The malignant cycle was frequently observed in depressed-type EGC. The improvement of ulceration in EGC was time dependent and associated with the usage of antisecretory medication and the depth of invasion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19296170     DOI: 10.1007/s00464-009-0434-2

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  22 in total

1.  Early gastric cancer: disease or pseudo-disease?

Authors:  S M Everett; A T Axon
Journal:  Lancet       Date:  1998-05-02       Impact factor: 79.321

2.  Prescription of proton pump inhibitors before endoscopy. A potential cause of missed diagnosis of early gastric cancers.

Authors:  J Wayman; N Hayes; S A Raimes; S M Griffin
Journal:  Arch Fam Med       Date:  2000-04

3.  Natural history of early gastric cancer: a non-concurrent, long term, follow up study.

Authors:  H Tsukuma; A Oshima; H Narahara; T Morii
Journal:  Gut       Date:  2000-11       Impact factor: 23.059

4.  Eighty months persistence of poorly differentiated early gastric cancer.

Authors:  V F Eckardt; D Willems; G Kanzler; W Remmele; U Bettendorf; W Paulus
Journal:  Gastroenterology       Date:  1984-09       Impact factor: 22.682

5.  Empirical use of antisecretory drug therapy delays diagnosis of upper gastrointestinal adenocarcinoma but does not effect outcome.

Authors:  S J Panter; H O'Flanagan; M G Bramble; A P S Hungin
Journal:  Aliment Pharmacol Ther       Date:  2004-05-01       Impact factor: 8.171

6.  Endoscopic analysis on the growth of early gastric carcinoma.

Authors:  E Kaneko; T Nakamura; M Fujino; N Umeda; H Niwa
Journal:  Gastroenterol Jpn       Date:  1979

7.  Detection of upper gastrointestinal cancer in patients taking antisecretory therapy prior to gastroscopy.

Authors:  M G Bramble; Z Suvakovic; A P Hungin
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

8.  Early gastric cancer: 46 cases treated in one surgical department.

Authors:  H M Sue-Ling; I Martin; J Griffith; D C Ward; P Quirke; M F Dixon; A T Axon; M J McMahon; D Johnston
Journal:  Gut       Date:  1992-10       Impact factor: 23.059

9.  Misleading response of malignant gastric ulcers to cimetidine.

Authors:  R H Taylor; N Menzies-Gow; D Lovell; S J La Brooy; J J Misiewicz
Journal:  Lancet       Date:  1978-04-01       Impact factor: 79.321

10.  Open-access gastroscopy is associated with improved outcomes in gastric cancer.

Authors:  Guy R Blackshaw; Jonathan D Barry; Paul Edwards; Miles C Allison; Wyn G Lewis
Journal:  Eur J Gastroenterol Hepatol       Date:  2003-12       Impact factor: 2.566

View more
  5 in total

1.  Do we have enough evidence for expanding the indications of ESD for EGC?

Authors:  Hang Lak Lee; Chang Hwan Choi; Dae Young Cheung
Journal:  World J Gastroenterol       Date:  2011-06-07       Impact factor: 5.742

2.  Effects of administration of a proton pump inhibitor before endoscopic submucosal dissection for differentiated early gastric cancer with ulcer.

Authors:  Yu Sik Myung; Su Jin Hong; Jae Pil Han; Kyung Woo Park; Bong Min Ko; Moon Sung Lee
Journal:  Gastric Cancer       Date:  2015-12-11       Impact factor: 7.370

3.  Morphologic pattern analysis of submucosal deformities identified by endoscopic ultrasonography for predicting the depth of invasion in early gastric cancer.

Authors:  Tae Young Kim; Nam Hee Yi; Jin Won Hwang; Ji Hyun Kim; Gwang Ha Kim; Mi Seon Kang
Journal:  Surg Endosc       Date:  2018-10-17       Impact factor: 4.584

4.  The Implications of Endoscopic Ulcer in Early Gastric Cancer: Can We Predict Clinical Behaviors from Endoscopy?

Authors:  Yoo Jin Lee; Jie-Hyun Kim; Jae Jun Park; Young Hoon Youn; Hyojin Park; Jong Won Kim; Seung Ho Choi; Sung Hoon Noh
Journal:  PLoS One       Date:  2016-10-14       Impact factor: 3.240

5.  Clinical Implication and Risk Factors for Malignancy of Atypical Gastric Gland during Forceps Biopsy.

Authors:  Min Seong Kim; Sang Gyun Kim; Hyunsoo Chung; Jung Kim; Hyoungju Hong; Hee Jong Lee; Hyun Ju Kim; Min A Kim; Woo Ho Kim; Hyun Chae Jung
Journal:  Gut Liver       Date:  2018-09-15       Impact factor: 4.519

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.